2019
2019
By December 31, Lu Daopei Hospitalcompleted a total of 1081 cases of hematopoietic stem cell transplantation inChina in 2019 and has treated approximately 800 patients by using CAR-Ttechnology in clinical treatment.


4 Oral reports and 6 posters in the 61st ASH


As the corresponding author and first author of the research report, President Peggy Lu and Director Zhang Xian made oral reports on behalf of the medical team. Two oral reports (abstract numbers: 224, 284) were listed in "ASH Highlights" and attracted much attention



The cooperation platform of the Institute of Biophysics of the Chinese Academy of Sciences, Beijing Win-win Biotech limited company and Lu Daopei Hospital was officially launched.


Beijing Lu Daopei Hospital successfully passed the GCP certification.

On October 31, 2019, the National Medical products Administration (NMPA) published on official website No. 86 of 2019, identifying 154 medical institutions such as Beijing Lu Daopei Hospital as qualified for clinical trials of medicine, and issued "Drug Clinical Trials Certificate of Institutional Qualification.


Academician Lu Daopei was awarded the "Celebrating the 70th Anniversary of the Founding of the People's Republic of China" Commemorative Medal


The 7th Lu Daopei Hematology Summit Forum was successfully held and V Love Charity Dinner was grandly opened

The 7th Lu Daopei Hematology Summit Forum, co-sponsored by Lu Daopei Medical Group ™ and Tsinghua University Medical College, was grandly opened at the Beijing International Convention Center on July 19, 2019. More than 1,200 well-known hematologists and colleagues from China, Europe, America, Asia Pacific and other regions attended the summit.

International Regenerative Medicine Foundation awarded Lu Daopei Medical Group the "Stem Cell and Regenerative Medicine Action Award"

Lu Daopei Medical Group from China won the only international achievement award.

Lu Daopei Medical Group Synarc Lab Zero Rectification Passed CAP Certification



First successful AML patient with CD 123 CAR-T bridge BMT

On December 27, 2018 (+29 days), Mr. Wu, who suffered from acute myeloid leukemia (AML),infusion  CD123-CAR-T cells at Lu Daopei Hospital and was successfully completed remission. Then the patient has been successfully bridged bone marrow transplantation and discharged with complete remission.

Hebei Yanda Lu Daopei Hospital Receives the highest honor"AAA Credit Evaluation" and "Five-Star Hospital"

Hebei Yanda Lu Daopei Hospital achieved best results in the "dual evaluation" activity carried out by the Chinese Association of Non-Public Medical Institutions, and awarded the highest honor"AAA Credit Evaluation" and "Five-Star Hospital" at the annual meeting of the Chinese Association of Non-Public Medical Institutions on January 6, 2019 .


Stay in Touch
©2017 Lu Daopei hospital-22 Tongji South Rd, Yizhuang Ecomonic and Technological Development Zone, Daxing District, Beijing, China. All rights reserved.
冀ICP备18002416号-1